Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.02 - $10.6 $18,360 - $190,800
-18,000 Reduced 58.44%
12,800 $0
Q2 2022

Aug 12, 2022

SELL
$0.97 - $1.77 $44,717 - $81,597
-46,100 Reduced 59.95%
30,800 $1,000
Q1 2022

May 12, 2022

BUY
$1.53 - $3.25 $74,052 - $157,300
48,400 Added 169.82%
76,900 $9,000
Q4 2021

Feb 14, 2022

BUY
$2.68 - $4.46 $76,380 - $127,110
28,500 New
28,500 $18,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $302M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.